Diabetes Dialogue: Time in Range, CGM Metrics for Predicting

Viral Shah, MD, joins Diabetes Dialogue to discuss a recent study examining associations between time in range and other advanced CGM metrics with diabetic retinopathy and the implications for use in predicting other microvascular outcomes.

Related Keywords

Natalie Bellini , Provention Bio , Diana Isaacs , Eli Lilly , Indiana University , Novo Nordisk , Training In Diabetes Technology , Medtronic , Metabolic Care Center , Dexcom Inc , Insulet Corporation , Diabetes Technology At University Hospitals , Aviral Shah , Diabetes Dialogue , Predict Diabetes , Incident Diabetic , Diabetes Technology , Endocrine Disorders , Cleveland Clinic , University Hospitals Diabetes , Metabolic Care , Tandem Diabetes Care , Abbott Diabetes Care , Time In Range , Continuous Glucose Monitoring , Cgm Metrics , Type 1 Diabetes , Time In Range And Diabetes , Time In Range And Diabetes Outcomes ,